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ĂAbstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S197Spain and UK populations. This association is probably due to a reduced
ROS production as a consequence of the climate adaptation of these
mtDNA haplogroups.
396
A GENOME-WIDE EXPRESSIONOFHUMANARTICULAROSTEOARTHRITIC
CARTILAGE SHOWS DIFFERENT GENE-EXPRESSION PROFILES RELATED
TO BOTH INFLAMMATORY AND IMMUNE RESPONSE PROCESSES
J. Fernández-Tajes, A. Soto-Hermida, M. Fernández-Moreno, M.E. Vázquez-
Mosquera, N. Oreiro-Villar, C. Fernández-López, E. Cortés-Pereira,
S. Relaño-Fernández, I. Rego-Pérez, F.J. Blanco. INIBIC-CHUAC, Genomic
Group. Rheumatology Div.., A Coruña, Spain
Purpose: To perform a genome-wide expression assay in order to identify
different expression proﬁles in the OA disease
Methods: Total RNA from OA cartilage samples was isolated with RNeasy
Kit (Qiagen, Madrin, Spain) following manufacturer’s instructions. RNA
was checked for integrity and purity with the Agilent Bioanalyzer (Agilent
Technologies) and NanoDrop spectrophotometer (Thermo Scientiﬁc). 150
nanograms of total RNA were used for cDNA synthesis using the Ambion
WT Expression kit (Ambion). The fragmented cDNAwas hybridized against
the Human Gene 1.1 ST array strip (Affymetrix) and scanned using the
GeneTitan system (Affymetrix). Quality controls, normalization, pre-pro-
cessing, differential gene expression and functional analyses were carried
out with Bioconductor packages using R software.
Results: Human Gene 1.1 ST Array, which interrogates more than 28,000
well-annotated genes of 33,297 probes, was used for studying the genome
wide expression proﬁle of 23 OA-patients tissue samples. A non-speciﬁc
ﬁltering was previously applied for removing those probes with non-
annotation information and with low intra-array variation. An unsuper-
vised machine learning approach revealed a group of samples highly
different (Figure 1). The differential expression analysis between this
cluster, comprising a total of ﬁve OA-patients, and the rest of the samples
allowed for the identiﬁcation of 176 differentially expressed probes with
an adjusted p value below 0.0001. The 20 differentially expressed probes
with higher log Fold Change are presented in Table 1. The analysis of the
biological processes related to these differentially expressed genes showed
that inﬂammation and immune processes were the main pathways found
to be altered when a gene set enrichment analysis was applied.
Conclusions: The genome-wide expression analysis shows a clearly
distinct proﬁle for a group of OA patients. Both inﬂammation and immune
response processes appeared to be altered and therefore are revealed as
key factors in the development of the OA disease.Ă397
IDENTIFICATION OF THE PATHOGENIC PATHWAYS IN OSTEOARTHRITIC
HIP CARTILAGE: COMMONALITY AND DISCORD BETWEEN HIP AND
KNEE OA
Y. Xu, M.J. Barter, D.C. Swan, K.S. Rankin, A.D. Rowan, M. Santibanez-
Koref, J. Loughlin, D.A. Young. Newcastle Univ., Newcastle upon Tyne,
United Kingdom
Purpose: To deﬁne for the ﬁrst time the transcriptome of normal and end-
stage osteoarthritic (OA) hip cartilage and to identify novel pathogenic
pathways involved in the disease.
Methods: RNA was isolated from articular cartilage samples obtained from
consented patients undergoing joint replacement surgery due to either end-
stage hip OA or neck of femur fracture (NOF). Illumina HumanHT-12 V3
whole genome expression arrayswere used to proﬁle gene expressions. Raw
data was analyzed and differentially expressed genes identiﬁed using the
Agilent Gene Spring GX 11 package. P-values were corrected for multiple
testing using the Benjamini-Hochberg method. Gene Set Enrichment Anal-
ysis (GSEA) and Ingenuity Pathway Analysis (IPA) were used to investigate
functions and pathways associated with these genes, respectively. Protein
interaction networks were predicted using STRING and visualized with
Medusa 3.0. Differentially expressed genes were veriﬁed by real-time PCR.
Results: In total we identiﬁed 1151 differentially expressed genes (fold
change  -1.5 or 1.5, P-value  0.01) between NOF (n¼10) and OA hip
(n¼9) cartilage. Sixty canonical pathways (P-value  0.05) were identiﬁed
as associated with these genes. A comparison between a published
comparable knee dataset only identiﬁed 183 genes similarly differentially
expressed but remarkably 35 canonical pathways overlapped between the
experiments. wnt/b-catenin signalling, PI3K/AKT signalling and IL-17 sig-
nalling pathways were identiﬁed in common between both studies.
Pathways such as glycosaminoglycan degradation (P-value¼0.044), HIF1a
signalling (P-value¼0.007) and interferon signalling (P-value¼0.003),
were speciﬁc to our hip OA study, while IGF-1 signalling, clathrin-medi-
ated endocytosis signalling and HMGB1 signalling were only associated
with the differentially expressed genes from knee OA cartilage.
Conclusions: This is the ﬁrst study to report a comprehensive gene
expression analysis of human hip OA cartilage compared to control (neck
of femur fracture) cartilage at the whole human genome level. Our
differential gene expression dataset shows excellent correlation with
similar deﬁned studies using comparable tissue but reveals discord
between hip and knee OA in the behavior of individual genes although
commonality with respect to the molecular pathways involved.
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MICROARRAY ANALYSIS OF GENE EXPRESSION IN PRIMARY HUMAN
OSTEOBLASTS DERIVED FROM SPINE
F. Moldovan, K. Fendri, S. Parent, C. Zaouter, A. Moreau,
K.S. Patten. Montreal Univ., Montreal, QC, Canada
